Latest news with #CleanScienceandTechnology
Business Standard
4 days ago
- Business
- Business Standard
Clean Science and Technology invests Rs 33 cr in Clean Fino-Chem
Clean Science and Technology has subscribed to the additional 5,51,840 equity hares of Rs.10 each at a premium of Rs. 588/- in lieu of subscription money of Rs. 33,00,00,320/- by way of subscription to the Rights Issue of Clean Fino-Chem, a wholly owned subsidiary of the Company. The said equity shares shall rank pari passu with the existing equity shares.
Mint
23-05-2025
- Business
- Mint
Mid-cap specialty chemical stock Clean Science rises 8% post Q4 results, dividend announcement. Time to buy or sell?
Stock Market Today: Mid-cap specialty chemical stock Clean Science gained more than 8% during the intraday trade on Friday following the announcement of its March quarter results (Q4) and dividend. Clean Science share price hit the day's high of ₹ 1447 on the BSE as against its last close of ₹ 1329.20. As of 2.30 pm, Clean Science stock was trading at ₹ 1431.60, up 7.70%. Clean Science and Technology, post-market hours on Thursday, said that its net profit increased by 5.89% from ₹ 70.09 crore in the January-March 2024 quarter to ₹ 74.23 crore in January-March 2025 quarter. The reported net sales for the March 2025 quarter for Clean Science and Technology stood at ₹ 263.68 crore, up 15.89% from March 2024's ₹ 227.53 crore. The earnings before interest, tax, depreciation and amortisation (EBITDA) increased by 7.91% from ₹ 108.57 crore in March 2024 to ₹ 117.16 crore in March 2025. Motilal Oswal Financial Services (MOFSL) expects Clean Science's revenue, EBITDA and net profit to grow at a compounded annual growth rate (CAGR) of 26%, 24% and 30% during FY25-27, respectively. The company is expected to generate around ₹ 190 crore in free cash flow during FY26-27, with a planned capex of ₹ 600 crore over the same period. The stock is currently trading at 32 times FY27 estimated earnings per share (EPS) of ₹ 42 and 23 times FY27 estimated EV/EBITDA. MOFSL values the stock at 30 times FY27 estimated EPS to arrive at their target price of ₹ 1,260. It has a 'Neutral' rating for the mid-cap chemical stock. Prabhudas Lilladher believes Clean Science Tech's new capex initiatives are expected to be key growth drivers. Clean Science construction has commenced on a second performance chemical plant focused on water treatment, which is scheduled to be operational by Q4FY26. However, the margin profile, as per Prabhudas Lilladher, may come under some pressure, as certain new products are expected to have lower profitability compared to the company's legacy portfolio. At its current valuation of 37 times FY27 EPS, the brokerage maintained a 'Hold' rating on Clean Science stock, with a target price of ₹ 1,361, valuing it at 38 times FY27 EPS. B&K Securities, however, has a 'Buy' Rating on the stock, with a target price of ₹ 1,716. B&K Securities' analysts say that based on the expanded HALS product basket, ongoing scale-up, and widening geographical footprint, the company expects to clock 4,500 MT volumes, garnering ₹ 210 crore revenue and capturing 65% of the domestic market share in HALS in the coming year. Two new performance products, slated for commercialisation in August 2025 and February 2026, are also expected to aid FY26E growth, while the legacy portfolio is expected to grow at around 5-6% YoY in line with the industry growth.
Mint
23-05-2025
- Business
- Mint
Mid-Cap Specialty chemical stock Clean Science risen 8% post Q4 results, Dividend announcement. Buy or Sell?
Stock Market Today: Mid-Cap Specialty chemical stock Clean Science gained more than 8% during the intraday trades on Friday post Q4 results and Dividend announcement on Thursday after the market hours. Should you Buy or Sell the Clean Science and Technology stock? The quarterly consolidated net profit reported by Mid-Cap Specialty chemical stock Clean Science and Technology increased by 5.89% from Rs. 70.09 crore in January - March 2024 quarter to Rs. 74.23 crore in January - March 2025 quarter. The reported net sales for the March 2025quarter for Clean Science and Technology Ltd stood at ₹ 263.68 crore, up 15.89% from March 2024's ₹ 227.53 crore. The Earnings before Interest Tax Depreciation and Amrotisation increased 7.91% from Rs. 108.57 crore in March 2024 to Rs. 117.16 crore in March 2025. Motilal Oswal Financial Services Ltd - For Mid-Cap Specialty chemical stock Clean Science and Technology Motilal Oswal Financial Services or MOFSL expects a revenue, Ebitda /EBITDA and net profit compounded annual growth of CAGR of 26%, 24% and 30% during FY25-27 respectively. The company is expected to generate around ₹ 190 Crore in Free Cash Flow during FY26-27, with a planned capex of ₹ 600 crore over the same period. The stock is currently trading at 32 times FY27 estimated Earnings per share or EPS of ₹ 42 and 23 times FY27 estimated EV/EBITDA. MOFSL value the stock at 30 times FY27 estimated EPS to arrive at their target price of ₹ 1,260 and hence have Neutral Ratings for the Mid-Cap Specialty chemical stock Clean Science Prabhudas Lilladher says that for or the Mid-Cap Specialty chemical stock Clean Science looking ahead, the new capex initiatives are expected to be key growth drivers. Clean Science construction has commenced on a second performance chemical plant focused on water treatment, which is scheduled to be operational by the margin profile as per Prabhudas Lilladher may come under some pressure, as certain new products are expected to have lower profitability compared to the company's legacy portfolio. At its current valuation of 37 times FY27 Earnings per Share, they maintain a 'Hold' rating on Clean Science, with a target price of ₹ 1,361 valuing it at 38 times FY27 EPS B&K Securities however has Buy Ratings for the Mid-Cap Specialty chemical stock Clean Science with a target price of ₹ 1716 B&K Securities analysts say that based on expanded HALS product basket, ongoing scale up, and widening geographical footprint, the company expects to clock 4,500 MT volumes garnering ₹ 210 Crore revenues and capturing 65% of domestic market share in HALS in the coming year. Mid Cap Specialty chemical stock Clean Science two new performance products, slated for commercialization in August-25 and February-26 are also expected to aid FY26E growth while legacy portfolio to grow at around 5-6% YoY in line with the industry growth. B&K Securities expects robust growth in FY27 backed by further scale-up from HALS and the newly introduced two performance products while supported by products such as DHDT, Barbituric Acid, and BHT. Disclaimer: The views and recommendations made above are those of individual analysts or broking companies, and not of Mint. We advise investors to check with certified experts before making any investment decisions.
